Analysis of the binding affinity of vascular endothelial growth factor A (VEGF) to ranibizumab, aflibercept and bevacizumab

被引:0
|
作者
Wang, Xiangdan [1 ]
Yang, Jihong [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
688; retina; 748 vascular endothelial growth factor;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1961
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    Papadopoulos, Nicholas
    Martin, Joel
    Ruan, Qin
    Rafique, Ashique
    Rosconi, Michael P.
    Shi, Ergang
    Pyles, Erica A.
    Yancopoulos, George D.
    Stahl, Neil
    Wiegand, Stanley J.
    [J]. ANGIOGENESIS, 2012, 15 (02) : 171 - 185
  • [2] Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
    Nicholas Papadopoulos
    Joel Martin
    Qin Ruan
    Ashique Rafique
    Michael P. Rosconi
    Ergang Shi
    Erica A. Pyles
    George D. Yancopoulos
    Neil Stahl
    Stanley J. Wiegand
    [J]. Angiogenesis, 2012, 15 : 171 - 185
  • [3] The Relative Affinities of Ranibizumab and Aflibercept for Vascular Endothelial Growth Factor A (VEGF) - an Analytical Ultracentrifugation Study
    Yadav, Sandeep
    Demeule, Barthelemy
    Liu, Jun
    Shire, Steven J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] In-vitro binding analysis of anti-human vascular endothelial growth factor antibodies bevacizumab and aflibercept with canine, feline, and equine vascular endothelial growth factor
    Muellerleile, Lisa-Marie
    Buxbaum, Bernhard
    Nell, Barbara
    Fux, Daniela A.
    [J]. RESEARCH IN VETERINARY SCIENCE, 2019, 124 : 233 - 238
  • [5] Evaluation of Aflibercept and Ziv-Aflibercept Binding Affinity to Vascular Endothelial Growth Factor, Stability, and Sterility after Compounding
    Farah, Julia Lima
    Sano, Ronaldo Yuiti
    Longo Maugeri, Ieda Maria
    Teixeira, Daniela
    Ishimura, Mayari Eika
    Martins, Gabriela
    Mimica, Lycia
    Silva, Cely
    Meyer, Carsten
    de Oliveira Dias, Joao Rafael
    Andrade, Gabriel Costa
    Farah, Michel Eid
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [6] Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding
    De Lima Farah J.
    Sano R.
    Maugéri I.M.L.
    Teixeira D.
    Ishimura M.E.
    Martins G.
    Mimica L.M.J.
    Da Silva C.B.
    Meyer C.H.
    De Oliveira Dias J.R.
    De Andrade G.C.
    Farah M.E.
    [J]. International Journal of Retina and Vitreous, 4 (1)
  • [7] CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA
    Hirano, Takao
    Toriyama, Yuichi
    Iesato, Yasuhiro
    Imai, Akira
    Murata, Toshinori
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (09): : 1801 - 1808
  • [8] Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times
    Fauser, Sascha
    Muether, Philipp S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (11) : 1494 - 1498
  • [9] PERMEABILITY AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO
    Yoshihara, Naoya
    Terasaki, Hiroto
    Shirasawa, Makoto
    Kawano, Hiroki
    Sonoda, Shozo
    Yamaguchi, Munekazu
    Hashiguchi, Teruto
    Hisatomi, Toshio
    Ishibashi, Tatsuro
    Sakamoto, Taiji
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (01): : 179 - 190
  • [10] SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY
    Wu, Wei-Chi
    Shih, Chia-Pang
    Lien, Reyin
    Wang, Nan-Kai
    Chen, Yen-Po
    Chao, An-Ning
    Chen, Kuan-Jen
    Chen, Tun-Lu
    Hwang, Yih-Shiou
    Lai, Chi-Chun
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (04): : 694 - 701